During the past decade, Ahana Hospitals conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ahana Hospitals" are "Schizophrenia" (2 trials). Many other conditions were trialed in "Ahana Hospitals" in a lesser frequency.

Most popular intervention types in "Ahana Hospitals" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Oral Antipsychotics (OAP)" (1 trials), "PP1M" (1 trials), "PP3M 350 mg eq." (1 trials), "PP3M 525 mg eq." (1 trials) and "PP6M" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ahana Hospitals" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Ahana Hospitals". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Ahana Hospitals, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ahana Hospitals, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".